The independent platform for news, articles and advice for professionals in laboratory medicine

RECENT NEWS

Aiosyn launches AI-powered mitosis detection solution

Aiosyn, a medical software company specialising in AI-powered pathology solutions, has released its first AI algorithm in its Mitosis product family: Aiosyn Mitosis Research. The innovative deep-learning algorithm is designed to automatically scan for cells undergoing division to assist research pathology laboratories with mitotic figure detection in whole-slide images from cancer biopsies and resections.

NHS England appoints Chief Information Officer

NHS England has appointed a new Chief Information Officer to oversee digital technology across the health service. John Quinn’s key responsibilities will include running and evolving the NHS’s critical technical infrastructure and managing cyber security for national services.

Randox acquires microfluidic tools and impedance flow cytometer developer Cellix

Global diagnostics company Randox has announced the completion of its acquisition of Cellix, a Dublin-based company that develops microfluidic tools and impedance flow cytometers for cell analysis.

Evident launches Slideview DX for microscope-quality images

The new Evident Slideview DX VS-M1 whole slide imaging system is a digital pathology solution that delivers high-quality slide images at high speed, helping pathologists make diagnoses quickly and efficiently. Built with renowned optics and advanced digital technology, the Slideview DX slide scanner is a complete digital pathology solution.

Mindpeak and Proscia partner to improve cancer diagnosis with AI

Mindpeak, a leading provider of artificial intelligence (AI) for pathology, and Proscia, a leading provider of digital and computational pathology solutions, have announced a partnership to broaden access to improved diagnosis for cancer patients.Through the collaboration, the companies lay the foundation for delivering tightly integrated AI-powered workflows that enable pathologists to provide more efficient, informed, and reproducible clinical decisions.

Yourgene Health demonstrates successful use of EDTA tubes for prenatal testing

Yourgene Health, a leading international molecular diagnostics group, has presented data demonstrating that prolonged storage of blood in EDTA tubes is compatible with non-invasive prenatal testing (NIPT) when using size selection to enrich the fetal fraction.

Sussex Pathology Network to deploy Clinisys LIMS

The Sussex Pathology Network has chosen Clinisys for a laboratory information management system (LIMS) that will help its laboratories to collaborate, building on the supportive relationship that developed during the COVID-19 pandemic. A single, hosted instance of WinPath Enterprise will replace the existing four live LIMS systems in use at the three trusts and seven laboratories within the network, of which two are at the end of their life.

H.E.L Group expands into new purpose-designed facilities

​H.E.L Group, a global developer and manufacturer of innovative laboratory tools for process optimisation, safety, and scale-up, today announced it will relocate its Greater London global headquarters from Borehamwood to Hemel Hempstead, over summer 2023. Overseen by interim Operational Director, Damian Slater, the move to new purpose-designed facilities supports the company’s continued expansion and plans for future growth.

RCPath celebrates National Pathology Week

This week The Royal College of Pathologists is celebrating National Pathology Week (NPW) - its annual celebration of pathology, highlighting the important contribution pathologists make to healthcare.

‘POCT: The power to disrupt’ comes to London

The next in the series of POCT events hosted by Thornhill Healthcare has been announced for London on 23 August, taking place at The Royal College of Pathologists in Aldgate.

Aiosyn expands its AI-powered QC for digital pathology to support IHC staining

Aiosyn, a software company that develops AI-powered pathology solutions, has announced the latest advancement in its automated quality control (QC) algorithm. Aiosyn’s QC solution, AiosynQC, is now fully compatible with immunohistochemistry (IHC) slides, in addition to haematoxylin and eosin (H&E) slides.

ProciseDx acquired by Biosynex to progress drug monitoring tests

ProciseDx has announced that it is being acquired by Biosynex, a French diagnostics company that specialises in point-of-care testing. With the support of the Biosynex Group, ProciseDx expects to commercialise the first FDA-approved infliximab and adalimumab drug monitoring tests later this year.

Submissions open for the 2023 Lab Awards

The Lab Awards, to be presented at the Lab Innovations show held in November, are back and bigger than ever at this year’s show, where winners will be crowned in categories such as sustainability, collaboration and innovation.

Paige enhances Breast Suite with improved AI

Digital pathology and clinical AI firm Paige has launched the enhanced Paige Breast Suite, a complete set of products designed to empower pathologists in their diagnosis of breast cancer, reduce the subjectivity and tedium of manual diagnosis, and increase diagnostic efficiency and confidence.

Oxford Nanopore and Geneyx to launch first scalable software for nanopore sequencing

Oxford Nanopore Technologies the company delivering a new generation of nanopore-based molecular sensing technology, and Geneyx, an AI platform for human genetic analysis and interpretation, are aiming to team up to develop the first scalable software solution for the end-to-end analysis and clinical reporting of nanopore sequencing data.

Digital pathology adopted by 70% of major pharmaceutical companies and CROs

Nearly three-quarters of life sciences organisations surveyed have invested in digital pathology to advance drug research and development, according to new research commissioned by Proscia. Over half of these organisations (53%) still centre their operations around legacy software systems primarily for basic image viewing despite growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics.

Government updates plans against biological threats

A new Biothreats Radar capable of scanning biological risks that pose a threat to the public will be key to the UK’s fight and preparation for future pandemics, the Government has announced. It’s part of a new Biological Security Strategy to defend the UK from infectious disease outbreaks, antimicrobial resistance, and biological incidents and attacks.

Major funding boost for cutting-edge leukaemia research

Scientists from across the UK are hoping to learn how they can better predict leukaemia occurrence, as well as develop improved drug screening pathways to treat the disease, through a major funding boost worth £12 million.

BIOHIT HealthCare to launch GastroPanel Quick Test

BIOHIT HealthCare will be launching its GastroPanel Quick Test at BSG LIVE’23, which will take place from 19-22 June at the Arena and Conference Centre (ACC) Liverpool. This annual meeting provides the ideal opportunity to share this innovation with colleagues in the gastroenterology and hepatology community, as they come together to discuss the latest advances in the field.

GrapheneDx, General Graphene Corp and Sapphiros partner to develop graphene-based biosensors for diagnostics

GrapheneDx, General Graphene Corporation and Sapphiros have announced a strategic partnership to industrialise graphene-based biosensors for medical devices used to diagnose a variety of diseases at the point of care and in consumer settings.

Upcoming Events

BIVDA Annual Regulatory Affairs Seminar

The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023

Drug Discovery 2023

ACC Exhibition Centre, Liverpool
18-19 October

MEEGID XVI

Hilton Dresden, Germany
14-17 November 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

BIVDA Annual Regulatory Affairs Seminar

The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023

Drug Discovery 2023

ACC Exhibition Centre, Liverpool
18-19 October

MEEGID XVI

Hilton Dresden, Germany
14-17 November 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2023 Step Communications Ltd. Registered in England. Registration Number 3893025